KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the grant of an inducement award to the Company’s recently appointed Chief Commercial Officer, Nicole Sweeny. In connection with Ms. Sweeny’s appointment, the compensation committee of KalVista’s bo...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Salisbury ,Mashonaland East ,Zimbabwe ,Nicole Sweeny ,Bryan Baker ,Jarrod Aldom ,Corporate Communications ,Nasdaq ,Kalvista Pharmaceuticals Inc ,Kalvista Pharmaceuticals ,Chief Commercial Officer ,Inducement Plan ,Nasdaq Listing Rule ,Vista Pharmaceuticals ,Investor Relations ,